Autoimmunity caused by constitutive activation of cytoplasmic viral RNA sensors

Cytokine and Growth Factor Reviews

Volumn 25, Issue 6, 2014, Pages 739-743

  Kato, Hiroki ^a,b   Fujita, Takashi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Japan Science and Technology Agency   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; MELANOMA DIFFERENTIATION ASSOCIATED GENE 5; UNCLASSIFIED DRUG; VIRUS RNA; DEAD BOX PROTEIN; IFIH1 PROTEIN, HUMAN;

AICARDI GOUTIERES SYNDROME; AUTOIMMUNITY; CONFORMATIONAL TRANSITION; CYTOKINE RESPONSE; GENE MUTATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; SHORT SURVEY; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; AUTOIMMUNE DISEASE; GENETICS; IMMUNOLOGY; VIRUS;

ANIMALS; AUTOIMMUNE DISEASES; DEAD-BOX RNA HELICASES; HUMANS; INTERFERONS; RNA, VIRAL; VIRUSES;

EID: 84918549600     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2014.08.003     Document Type: Short Survey

References (53)

1. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-650.
2. Yoo J.S., Kato H., Fujita T. Sensing viral invasion by RIG-I like receptors. Curr Opin Microbiol 2014, 20C:131-138.
3. Xiao T.S., Fitzgerald K.A. The cGAS-STING pathway for DNA sensing. Mol Cell 2013, 51:135-139.
4. Diamond M.S., Farzan M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol 2013, 13:46-57.
5. Hooks J.J., Moutsopoulos H.M., Notkins A.L. The role of interferon in immediate hypersensitivity and autoimmune diseases. Ann NY Acad Sci 1980, 350:21-32.
6. Higgs B.W., Liu Z., White B., Zhu W., White W.I., et al. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. Ann Rheum Dis 2011, 70:2029-2036.
7. Crow M.K. Advances in understanding the role of type I interferons in systemic lupus erythematosus. Curr Opin Rheumatol 2014, 26:467-474.
8. Funabiki M., Kato H., Miyachi Y., Toki H., Motegi H., et al. Autoimmune disorders associated with gain of function of the intracellular sensor MDA5. Immunity 2014, 40:199-212.
9. Miner J.J., Diamond M.S. MDA5 and autoimmune disease. Nat Genet 2014, 46:418-419.
10. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004, 5:730-737.
11. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105.
12. Satoh T., Kato H., Kumagai Y., Yoneyama M., Sato S., et al. LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. PNAS 2010, 107:1512-1517.
13. Venkataraman T., Valdes M., Elsby R., Kakuta S., Caceres G., et al. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J Immunol 2007, 178:6444-6455.
14. Luo D., Ding S.C., Vela A., Kohlway A., Lindenbach B.D., et al. Structural insights into RNA recognition by RIG-I. Cell 2011, 147:409-422.
15. Kageyama M., Takahasi K., Narita R., Hirai R., Yoneyama M., et al. 55 Amino acid linker between helicase and carboxyl terminal domains of RIG-I functions as a critical repression domain and determines inter-domain conformation. Biochem Biophys Res Commun 2011, 415:75-81.
16. Yoneyama M., Kikuchi M., Matsumoto K., Imaizumi T., Miyagishi M., et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 2005, 175:2851-2858.
17. Hornung V., Ellegast J., Kim S., Brzozka K., Jung A., et al. 5'-Triphosphate RNA is the ligand for RIG-I. Science 2006, 314:994-997.
18. Pichlmair A., Schulz O., Tan C.P., Naslund T.I., Liljestrom P., et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006, 314:997-1001.
19. Schlee M., Roth A., Hornung V., Hagmann C.A., Wimmenauer V., et al. Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 2009, 31:25-34.
20. Schmidt A., Schwerd T., Hamm W., Hellmuth J.C., Cui S., et al. 5'-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. PNAS 2009, 106:12067-12072.
21. Rehwinkel J., Tan C.P., Goubau D., Schulz O., Pichlmair A., et al. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 2010, 140:397-408.
22. Patel J.R., Jain A., Chou Y.Y., Baum A., Ha T., et al. ATPase-driven oligomerization of RIG-I on RNA allows optimal activation of type-I interferon. EMBO Rep 2013, 14:780-787.
23. Kato H., Takeuchi O., Mikamo-Satoh E., Hirai R., Kawai T., et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 2008, 205:1601-1610.
24. Takahasi K., Yoneyama M., Nishihori T., Hirai R., Kumeta H., et al. Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell 2008, 29:428-440.
25. Seth R.B., Sun L., Ea C.K., Chen Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005, 122:669-682.
26. Kawai T., Takahashi K., Sato S., Coban C., Kumar H., et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005, 6:981-988.
27. Xu L.G., Wang Y.Y., Han K.J., Li L.Y., Zhai Z., et al. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 2005, 19:727-740.
28. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437:1167-1172.
29. Sun Q., Sun L., Liu H.H., Chen X., Seth R.B., et al. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 2006, 24:633-642.
30. Kumar H., Kawai T., Kato H., Sato S., Takahashi K., et al. Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med 2006, 203:1795-1803.
31. Wu B., Peisley A., Richards C., Yao H., Zeng X., et al. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 2013, 152:276-289.
32. Hou F., Sun L., Zheng H., Skaug B., Jiang Q.X., et al. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 2011, 146:448-461.
33. Onoguchi K., Onomoto K., Takamatsu S., Jogi M., Takemura A., et al. Virus-infection or 5'ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1. PLoS Pathog 2010, 6:e1001012.
34. Onomoto K., Jogi M., Yoo J.S., Narita R., Morimoto S., et al. Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity. PLoS One 2012, 7:e43031.
35. Yoo J.S., Takahasi K., Ng C.S., Ouda R., Onomoto K., et al. DHX36 enhances RIG-I signaling by facilitating PKR-mediated antiviral stress granule formation. PLoS Pathog 2014, 10:e1004012.
36. Poeck H., Bscheider M., Gross O., Finger K., Roth S., et al. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat Immunol 2010, 11:63-69.
37. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
38. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303:1526-1529.
39. Diebold S.S., Kaisho T., Hemmi H., Akira S., Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303:1529-1531.
40. Deane J.A., Pisitkun P., Barrett R.S., Feigenbaum L., Town T., et al. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 2007, 27:801-810.
41. Pisitkun P., Deane J.A., Difilippantonio M.J., Tarasenko T., Satterthwaite A.B., et al. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 2006, 312:1669-1672.
42. Napirei M., Karsunky H., Zevnik B., Stephan H., Mannherz H.G., et al. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 2000, 25:177-181.
43. Robinson T., Kariuki S.N., Franek B.S., Kumabe M., Kumar A.A., et al. Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-alpha and serologic autoimmunity in lupus patients. J Immunol 2011, 187:1298-1303.
44. Crampton S.P., Deane J.A., Feigenbaum L., Bolland S. Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity. J Immunol 2012, 188:1451-1459.
45. Crow Y.J., Rehwinkel J. Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum Mol Genet 2009, 18:R130-R136.
46. Sun L., Wu J., Du F., Chen X., Chen Z.J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013, 339:786-791.
47. Ishikawa H., Ma Z., Barber G.N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009, 461:788-792.
48. Crow Y.J., Hayward B.E., Parmar R., Robins P., Leitch A., et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus. Nat Genet 2006, 38:917-920.
49. Lee-Kirsch M.A., Gong M., Chowdhury D., Senenko L., Engel K., et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 2007, 39:1065-1067.
50. Rice G.I., del Toro Duany Y., Jenkinson E.M., Forte G.M., Anderson B.H., et al. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet 2014, 46:503-509.
51. Oda H., Nakagawa K., Abe J., Awaya T., Funabiki M., et al. Aicardi-Goutieres syndrome is caused by IFIH1 mutations. Am J Hum Genet 2014, 95:121-125.
52. Nejentsev S., Walker N., Riches D., Egholm M., Todd J.A. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009, 324:387-389.
53. Jaidane H., Hober D. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabete Metab 2008, 34:537-548.